Mazen Noureddin (Mazen Noureddine, M Noureddin)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 54

Top Topics

Systematic Review

Glycemic Control

Top Venues

Alimentary pharmacology & therapeutics

Hepatology (Baltimore, Md.)

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine (2024)
Wah-Kheong Chan, Salvatore Petta, Mazen Noureddin, George Boon Bee Goh, Vincent Wai-Sun Wong
Diagnosis and non-invasive assessment of MASLD in type 2 diabetes and obesity. Alimentary pharmacology & therapeutics (2024)
Wah-Kheong Chan, Salvatore Petta, Mazen Noureddin, George Boon Bee Goh, Vincent Wai-Sun Wong
Diagnosis and non-invasive assessment of MASLD in type 2 diabetes and obesity. Alimentary pharmacology & therapeutics (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine 136 (3) (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine 136 (3) (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis. Alimentary pharmacology & therapeutics 59 (6) (2024)
Mazen Noureddin
MASH clinical trials and drugs pipeline: An impending tsunami. Hepatology (Baltimore, Md.) (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis. Alimentary pharmacology & therapeutics 59 (6) (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine (2024)
Pojsakorn Danpanichkul, Majd B Aboona, Banthoon Sukphutanan, Siwanart Kongarin, Kwanjit Duangsonk, Cheng-Han Ng, Mark Dhinesh Muthiah, Daniel Q Huang, Yuya Seko, Luis Antonio Diaz, Juan Pablo Arab, Ju Dong Yang, Vincent L Chen, Donghee Kim, Mazen Noureddin, Suthat Liangpunsakul, Karn Wijarnpreecha
Incidence of liver cancer in young adults according to the Global Burden of Disease database 2019. Hepatology (Baltimore, Md.) (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis. Alimentary pharmacology & therapeutics 59 (6) (2024)
Wah-Kheong Chan, Salvatore Petta, Mazen Noureddin, George Boon Bee Goh, Vincent Wai-Sun Wong
Diagnosis and non-invasive assessment of MASLD in type 2 diabetes and obesity. Alimentary pharmacology & therapeutics (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis. Alimentary pharmacology & therapeutics 59 (6) (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis: Systematic review and meta-analysis. Alimentary pharmacology & therapeutics (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis: Systematic review and meta-analysis. Alimentary pharmacology & therapeutics (2024)
Cheng-Han Ng, Kai En Chan, Mark Muthiah, Caitlyn Tan, Phoebe Tay, Wen Hui Lim, Darren Jun Hao Tan, Clarissa Elysia Fu, Jie Ning Yong, Zhen Yu Wong, Benjamin Koh, Nicholas Ws Chew, Nicholas Syn, Daniel Q Huang, Yock Young Dan, Mohammad S Siddiqui, Arun J Sanyal, Mazen Noureddin
Examining the interim proposal for name change to steatotic liver disease in the US population. Hepatology (Baltimore, Md.) (2023)
Clarissa Elysia Fu, Jie Ning Yong, Cheng-Han Ng, Benjamin Nah, Nicholas W S Chew, Yip Han Chin, Gwyneth Kong, Darren Jun Hao Tan, Wen Hui Lim, Lincoln Kai En Lim, Rebecca Wenling Zeng, Asim Shabbir, Eunice X X Tan, Daniel Q Huang, Chin Meng Khoo, Mohammad Shadab Siddqui, Mark Y Y Chan, Mazen Noureddin, Mamas A Mamas, Mark Dhinesh Muthiah
Original article: The prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndrome. Alimentary pharmacology & therapeutics (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Mohammad A Karim, Amit G Singal, Hye Chung Kum, Yi-Te Lee, Sulki Park, Nicole E Rich, Mazen Noureddin, Ju Dong Yang
Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis. Cancer research communications 3 (5) (2023)
Pojsakorn Danpanichkul, Cheng-Han Ng, Mark Dhinesh Muthiah, Kwanjit Duangsonk, Jie Ning Yong, Darren Jun Hao Tan, Wen Hui Lim, Zhen Yu Wong, Nicholas Li-Xun Syn, Tsubasa Tsusumi, Hirokazu Takahashi, Mohammad Shadab Siddiqui, Vincent Wai-Sun Wong, Christos S Mantzoros, Daniel Q Huang, Mazen Noureddin, Rohit Loomba, Arun J Sanyal, Karn Wijarnpreecha
The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysis. Alimentary pharmacology & therapeutics (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Mazen Noureddin, Zachary Goodman, Dean Tai, Elaine L K Chng, Yayun Ren, Pol Boudes, Harold Shlevin, Guadalupe Garcia-Tsao, Stephen A Harrison, Naga P Chalasani
Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis. Alimentary pharmacology & therapeutics (2023)
Mazen Noureddin, Zachary Goodman, Dean Tai, Elaine L K Chng, Yayun Ren, Pol Boudes, Harold Shlevin, Guadalupe Garcia-Tsao, Stephen A Harrison, Naga P Chalasani
Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis. Alimentary pharmacology & therapeutics 57 (4) (2023)
Cheng-Han Ng, Kai En Chan, Mark Muthiah, Caitlyn Tan, Phoebe Tay, Wen Hui Lim, Darren Jun Hao Tan, Clarissa Elysia Fu, Jie Ning Yong, Zhen Yu Wong, Benjamin Koh, Nicholas Ws Chew, Nicholas Syn, Daniel Q Huang, Yock Young Dan, Mohammad S Siddiqui, Arun J Sanyal, Mazen Noureddin
Examining the interim proposal for name change to steatotic liver disease in the US population. Hepatology (Baltimore, Md.) (2023)
Mohammad A Karim, Amit G Singal, Hye Chung Kum, Yi-Te Lee, Sulki Park, Nicole E Rich, Mazen Noureddin, Ju Dong Yang
Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis. Cancer research communications 3 (5) (2023)
Clarissa Elysia Fu, Jie Ning Yong, Cheng-Han Ng, Benjamin Nah, Nicholas W S Chew, Yip Han Chin, Gwyneth Kong, Darren Jun Hao Tan, Wen Hui Lim, Lincoln Kai En Lim, Rebecca Wenling Zeng, Asim Shabbir, Eunice X X Tan, Daniel Q Huang, Chin Meng Khoo, Mohammad Shadab Siddqui, Mark Y Y Chan, Mazen Noureddin, Mamas A Mamas, Mark Dhinesh Muthiah
Original article: The prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndrome. Alimentary pharmacology & therapeutics (2023)
Mazen Noureddin, Zachary Goodman, Dean Tai, Elaine L K Chng, Yayun Ren, Pol Boudes, Harold Shlevin, Guadalupe Garcia-Tsao, Stephen A Harrison, Naga P Chalasani
Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis. Alimentary pharmacology & therapeutics 57 (4) (2023)
Mazen Noureddin, Edward Mena, Raj K Vuppalanchi, Niharika R Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Chang, Nabil Noureddin, Anita Kohli, Stephen A Harrison, Samer Gwarieh, Rohit L Loomba, Emily Truong
Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores. Hepatology communications 7 (5) (2023)
Cheng-Han Ng, Kai En Chan, Mark Muthiah, Caitlyn Tan, Phoebe Tay, Wen Hui Lim, Darren Jun Hao Tan, Clarissa Elysia Fu, Jie Ning Yong, Zhen Yu Wong, Benjamin Koh, Nicholas Ws Chew, Nicholas Syn, Daniel Q Huang, Yock Young Dan, Mohammad S Siddiqui, Arun J Sanyal, Mazen Noureddin
Examining the interim proposal for name change to steatotic liver disease in the US population. Hepatology (Baltimore, Md.) (2023)
Mohammad A Karim, Amit G Singal, Hye Chung Kum, Yi-Te Lee, Sulki Park, Nicole E Rich, Mazen Noureddin, Ju Dong Yang
Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis. Cancer research communications 3 (5) (2023)
Mohammad A Karim, Amit G Singal, Hye Chung Kum, Yi-Te Lee, Sulki Park, Nicole E Rich, Mazen Noureddin, Ju Dong Yang
Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis. Cancer research communications 3 (5) (2023)
Mohammad A Karim, Amit G Singal, Hye Chung Kum, Yi-Te Lee, Sulki Park, Nicole E Rich, Mazen Noureddin, Ju Dong Yang
Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis. Cancer research communications 3 (5) (2023)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Issacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2022)
Pai-Chi Teng, Daniel Q Huang, Ting-Yi Lin, Mazen Noureddin, Ju Dong Yang
Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease. Gut and liver (2022)
Jieling Xiao, Cheng-Han Ng, Yip-Han Chin, Darren Jun Hao Tan, Wen-Hui Lim, Grace Lim, Jingxuan Quek, Ansel Shao Pin Tang, Kai-En Chan, Rou-Yi Soong, Nicholas W S Chew, Benjamin Tay, Daniel Q Huang, Nobuharu Tamaki, Roger Sik Yin Foo, Mark Yan-Yee Chan, Mazen Noureddin, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Dhinesh Muthiah
A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for Dyslipidemia. Journal of clinical and translational hepatology 10 (6) (2022)
Ibon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, Ruben Gil-Redondo, Itziar Mincholé, Maider Bizkarguenaga, Enara Arretxe, Marta Iruarrizaga-Lejarreta, David Fernández-Ramos, Fernando Lopitz-Otsoa, Rebeca Mayo, Nieves Embade, Elizabeth Newberry, Bettina Mittendorf, Laura Izquierdo-Sánchez, Vaclav Smid, Jorge Arnold, Paula Iruzubieta, Ylenia Pérez Castaño, Marcin Krawczyk, Urko M Marigorta, Martine C Morrison, Robert Kleemann, Antonio Martín-Duce, Liat Hayardeny, Libor Vítek, Radan Brůha, Rocío Aller de la Fuente, Javier Crespo, Manuel Romero, Jesus M Banales, Marco Arrese, Kenneth Cusi, Elisabetta Bugianesi, Samuel Klein, Shelly C Lu, Quentin Mark Anstee, Óscar Millet, Nicholas O Davidson, Cristina Alonso, Jose M Mato
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles. Hepatology (Baltimore, Md.) 76 (4) (2022)
Cheng-Han Ng, Wen Hui Lim, Yip Han Chin, Jie Ning Yong, Rebecca Wenling Zeng, Kai En Chan, Darren Jun Hao Tan, Clarissa Elysia Fu, Ansel Shao Pin Tang, Lay Hoon Goh, Kamala Devi, Nicholas W S Chew, Lung-Yi Loey Mak, Nobuharu Tamaki, Daniel Q Huang, Mazen Noureddin, Mohammad Shadab Siddiqui, Stephen Caldwell, Arun J Sanyal, Mark Dhinesh Muthiah
Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives. Alimentary pharmacology & therapeutics 56 (4) (2022)
Pai-Chi Teng, Daniel Q Huang, Ting-Yi Lin, Mazen Noureddin, Ju Dong Yang
Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease. Gut and liver 17 (1) (2022)
Pai-Chi Teng, Daniel Q Huang, Ting-Yi Lin, Mazen Noureddin, Ju Dong Yang
Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease. Gut and liver 17 (1) (2022)
Alfred Sidney Barritt, Emma Marshman, Mazen Noureddin
Review article: role of glucagon-like peptide-1 receptor agonists in non-alcoholic steatohepatitis, obesity and diabetes-what hepatologists need to know. Alimentary pharmacology & therapeutics 55 (8) (2022)
Pai-Chi Teng, Daniel Q Huang, Ting-Yi Lin, Mazen Noureddin, Ju Dong Yang
Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease. Gut and liver 17 (1) (2022)
Pai-Chi Teng, Daniel Q Huang, Ting-Yi Lin, Mazen Noureddin, Ju Dong Yang
Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease. Gut and liver 17 (1) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Cheng-Han Ng, Mark Dhinesh Muthiah, Jieling Xiao, Yip Han Chin, Grace Lim, Wen Hui Lim, Phoebe Tay, Darren Jun Hao Tan, Jie Ning Yong, Xin-Hui Pan, Jeffery Wei Heng Koh, Nicholas Chew, Nicholas Li-Xun Syn, Eunice Tan, Daniel Q Huang, Mohammad Shadab Siddiqui, Stephen Caldwell, Arun J Sanyal, Mazen Noureddin
Meta-analysis: analysis of mechanistic pathways in the treatment of non-alcoholic steatohepatitis. Evidence from a Bayesian network meta-analysis. Alimentary pharmacology & therapeutics 55 (9) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Pai-Chi Teng, Daniel Q Huang, Ting-Yi Lin, Mazen Noureddin, Ju Dong Yang
Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease. Gut and liver 17 (1) (2022)
Justin A Steggerda, Nabil Noureddin, Naim Alkhouri, Tsuyoshi Todo, Ju Dong Yang, Irene K Kim, Mazen Noureddin
Sex differences in age at wait-list registration for liver transplantation with nonalcoholic steatohepatitis as primary indication. Clinical transplantation 35 (2) (2020)
Yoon Mee Yang, Mazen Noureddin, Cheng Liu, Koichiro Ohashi, So Yeon Kim, Divya Ramnath, Elizabeth E Powell, Matthew J Sweet, Yoon Seok Roh, I-Fang Hsin, Nan Deng, Zhenqiu Liu, Jiurong Liang, Edward Mena, Daniel Shouhed, Robert F Schwabe, Dianhua Jiang, Shelly C Lu, Paul W Noble, Jeffrey H Albrecht
Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis. Science translational medicine 11 (496) (2020)
Zobair M Younossi, Kathleen E Corey, Naim Alkhouri, Mazen Noureddin, Ira Jacobson, Brian Lam, Stephen Clement, Rita Basu, Stuart C Gordon, Natarajan Ravendhra, Puneet Puri, Mary Rinella, Peter Scudera, Ashwani K Singal, Linda Henry, null null
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices. Alimentary pharmacology & therapeutics 52 (3) (2020)
Mazen Noureddin, Stephen Caldwell
Editorial: role of leucine-metformin-sildenafil combination in the treatment of nonalcoholic fatty liver disease (NAFLD). Alimentary pharmacology & therapeutics 48 (3) (2019)